Alakulppi Noora S, Kyllönen Lauri E, Jäntti Virva T, Matinlauri Irma H, Partanen Jukka, Salmela Kaija T, Laine Jarmo T
Stem Cell and Transplantation Services, Finnish Red Cross Blood Service, Kivihaantie 7, SF-00310 Helsinki, Finland.
Transplantation. 2004 Nov 27;78(10):1422-8. doi: 10.1097/01.tp.0000140884.71571.bc.
Pretransplantation identification of patients at an increased risk for adverse events would allow more individualized treatment strategies possibly improving long-term outcome. We studied cytokine gene polymorphisms of kidney allograft recipients and their donors to identify factors predisposing for acute rejection (AR) and delayed graft function (DGF).
A total of 291 adult cadaver kidney recipients transplanted at a single transplantation centre between 1999 and 2002 were investigated. Recipients and donors were typed for TNF-alpha(-308G/A), TGF-beta1(codon 10T/C, codon 25C/G), IL-10(-1082G/A, -819C/T, -592C/A), IL-6(-174C/G), and IFN-gamma(+874T/A) polymorphisms using a SSP-PCR kit. An AR episode was defined based on clinical and histological findings (Banff criteria). RESULTS.: The incidence of AR was 17%. In univariate statistical analyses recipients with TNF-alpha -308AA-genotype were found to be at a significantly increased risk for rejection (odds ratio [OR] 5.0, 95% CI 3.0-8.3, P = 0.003). The association was independent from the patient-donor HLA-mismatch status. In addition, patients with IL-10 ACCACC, ATAATA, GCCATA (-1082A/G, -819C/T, -592C/A, respectively) haplotypes were predisposed to rejection (OR 1.9, 95% CI 1.1-3.1, P = 0.016). Further, the combination of recipient TGF-beta1 25GG-genotype and donor IL-10 -819T-allele was associated with rejection (OR 1.8, 95% CI 1.1-3.0, P = 0.027). These variables remained significant risk factors also in a multivariate logistic regression analysis. The incidence of DGF was 22%. The risk was increased by a donor TNF-alpha -308GA-genotype (OR 1.6, 95% CI 1.1-2.6, P = 0.040).
Our results confirm that cytokine gene polymorphisms influence the outcome of kidney transplantation. Our data especially identify the TNF-alpha -308AA-genotype as a factor predisposing for AR episodes.
移植前识别不良事件风险增加的患者,将有助于制定更个体化的治疗策略,可能改善长期预后。我们研究了肾移植受者及其供者的细胞因子基因多态性,以确定急性排斥反应(AR)和移植肾功能延迟恢复(DGF)的易感因素。
对1999年至2002年间在单一移植中心接受移植的291例成年尸体肾受者进行了研究。使用SSP-PCR试剂盒对受者和供者进行肿瘤坏死因子-α(-308G/A)、转化生长因子-β1(密码子10T/C、密码子25C/G)、白细胞介素-10(-1082G/A、-819C/T、-592C/A)、白细胞介素-6(-174C/G)和干扰素-γ(+874T/A)基因多态性分型。根据临床和组织学结果(班夫标准)定义AR发作。结果:AR的发生率为17%。在单因素统计分析中,发现肿瘤坏死因子-α -308AA基因型的受者排斥反应风险显著增加(优势比[OR]5.0,95%可信区间3.0-8.3,P = 0.003)。这种关联独立于患者-供者HLA错配状态。此外,白细胞介素-10 ACCACC、ATAATA、GCCATA(分别为-1082A/G、-819C/T、-592C/A)单倍型的患者易发生排斥反应(OR 1.9,95%可信区间1.1-3.1,P = 0.016)。此外,受者转化生长因子-β1 25GG基因型与供者白细胞介素-10 -819T等位基因的组合与排斥反应相关(OR 1.8,95%可信区间1.1-3.0,P = 0.027)。在多因素逻辑回归分析中,这些变量也仍然是显著的危险因素。DGF的发生率为22%。供者肿瘤坏死因子-α -308GA基因型增加了风险(OR 1.6,95%可信区间1.1-2.6,P = 0.040)。
我们的结果证实细胞因子基因多态性影响肾移植的预后。我们的数据特别确定肿瘤坏死因子-α -308AA基因型是AR发作的易感因素。